316 related articles for article (PubMed ID: 17341531)
1. Retisert: is the new advance in treatment of uveitis a good one?
Mohammad DA; Sweet BV; Elner SG
Ann Pharmacother; 2007 Mar; 41(3):449-54. PubMed ID: 17341531
[TBL] [Abstract][Full Text] [Related]
2. Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study.
Jaffe GJ; Martin D; Callanan D; Pearson PA; Levy B; Comstock T;
Ophthalmology; 2006 Jun; 113(6):1020-7. PubMed ID: 16690128
[TBL] [Abstract][Full Text] [Related]
3. A comparison between the fluocinolone acetonide (Retisert) and dexamethasone (Ozurdex) intravitreal implants in uveitis.
Arcinue CA; Cerón OM; Foster CS
J Ocul Pharmacol Ther; 2013 Jun; 29(5):501-7. PubMed ID: 23297752
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis.
Jaffe GJ; McCallum RM; Branchaud B; Skalak C; Butuner Z; Ashton P
Ophthalmology; 2005 Jul; 112(7):1192-8. PubMed ID: 15921758
[TBL] [Abstract][Full Text] [Related]
5. Reimplantation of a fluocinolone acetonide sustained drug delivery implant for chronic uveitis.
Jaffe GJ
Am J Ophthalmol; 2008 Apr; 145(4):667-675. PubMed ID: 18226800
[TBL] [Abstract][Full Text] [Related]
6. Combined fluocinolone acetonide intraocular delivery system insertion, phacoemulsification, and intraocular lens implantation for severe uveitis.
Chieh JJ; Carlson AN; Jaffe GJ
Am J Ophthalmol; 2008 Oct; 146(4):589-594. PubMed ID: 18639220
[TBL] [Abstract][Full Text] [Related]
7. Treatment of intractable posterior uveitis in pediatric patients with the fluocinolone acetonide intravitreal implant (Retisert).
Patel CC; Mandava N; Oliver SC; Braverman R; Quiroz-Mercado H; Olson JL
Retina; 2012 Mar; 32(3):537-42. PubMed ID: 21963487
[TBL] [Abstract][Full Text] [Related]
8. Outcome of fluocinolone acetonide implant (Retisert) reimplantation for chronic noninfectious posterior uveitis.
Taban M; Lowder CY; Kaiser PK
Retina; 2008 Oct; 28(9):1280-8. PubMed ID: 18628725
[No Abstract] [Full Text] [Related]
9. Combined fluocinolone acetonide intravitreal insertion and glaucoma drainage device placement for chronic uveitis and glaucoma.
Malone PE; Herndon LW; Muir KW; Jaffe GJ
Am J Ophthalmol; 2010 May; 149(5):800-6.e1. PubMed ID: 20189158
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of an intravitreal fluocinolone acetonide implant versus standard systemic therapy in noninfectious posterior uveitis.
Pavesio C; Zierhut M; Bairi K; Comstock TL; Usner DW;
Ophthalmology; 2010 Mar; 117(3):567-75, 575.e1. PubMed ID: 20079922
[TBL] [Abstract][Full Text] [Related]
11. Dexamethasone for ocular inflammation.
Saraiya NV; Goldstein DA
Expert Opin Pharmacother; 2011 May; 12(7):1127-31. PubMed ID: 21457057
[TBL] [Abstract][Full Text] [Related]
12. Fluocinolone acetonide ophthalmic--Bausch & Lomb: fluocinolone acetonide Envision TD implant.
Drugs R D; 2005; 6(2):116-9. PubMed ID: 15777105
[TBL] [Abstract][Full Text] [Related]
13. Retisert (Bausch & Lomb/Control Delivery Systems).
Lim LL; Smith JR; Rosenbaum JT
Curr Opin Investig Drugs; 2005 Nov; 6(11):1159-67. PubMed ID: 16312138
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus retinitis after fluocinolone acetonide (Retisert) implant.
Ufret-Vincenty RL; Singh RP; Lowder CY; Kaiser PK
Am J Ophthalmol; 2007 Feb; 143(2):334-5. PubMed ID: 17258523
[TBL] [Abstract][Full Text] [Related]
15. New developments in corticosteroid therapy for uveitis.
Taylor SR; Isa H; Joshi L; Lightman S
Ophthalmologica; 2010; 224 Suppl 1():46-53. PubMed ID: 20714181
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of fluocinolone acetonide sustained release implant (Retisert) dissociation during implant removal and exchange surgery.
Nicholson BP; Singh RP; Sears JE; Lowder CY; Kaiser PK
Am J Ophthalmol; 2012 Dec; 154(6):969-973.e1. PubMed ID: 22981365
[TBL] [Abstract][Full Text] [Related]
17. Late spontaneous dissociation of a fluocinolone acetonide implant (Retisert).
Rofagha S; Prechanond T; Stewart JM
Ocul Immunol Inflamm; 2013; 21(1):77-8. PubMed ID: 23323586
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus endotheliitis after fluocinolone acetonide (Retisert) implant in a patient with Behçet uveitis.
Park UC; Kim SJ; Yu HG
Ocul Immunol Inflamm; 2011 Aug; 19(4):282-3. PubMed ID: 21770807
[TBL] [Abstract][Full Text] [Related]
19. Association Between Long-Lasting Intravitreous Fluocinolone Acetonide Implant vs Systemic Anti-inflammatory Therapy and Visual Acuity at 7 Years Among Patients With Intermediate, Posterior, or Panuveitis.
; Kempen JH; Altaweel MM; Holbrook JT; Sugar EA; Thorne JE; Jabs DA
JAMA; 2017 May; 317(19):1993-2005. PubMed ID: 28477440
[TBL] [Abstract][Full Text] [Related]
20. Dissociations of the Fluocinolone Acetonide Implant: The Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study.
Holbrook JT; Sugar EA; Burke AE; Vitale AT; Thorne JE; Davis JL; Jabs DA;
Am J Ophthalmol; 2016 Apr; 164():29-36. PubMed ID: 26748056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]